2-(3,4-Dihydroxy-phenyl)-benzothiazole-4,6-diol

ID: ALA48085

Chembl Id: CHEMBL48085

PubChem CID: 135407125

Max Phase: Preclinical

Molecular Formula: C13H9NO4S

Molecular Weight: 275.29

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Oc1cc(O)c2nc(-c3ccc(O)c(O)c3)sc2c1

Standard InChI:  InChI=1S/C13H9NO4S/c15-7-4-10(18)12-11(5-7)19-13(14-12)6-1-2-8(16)9(17)3-6/h1-5,15-18H

Standard InChI Key:  XWVVZTQPCQUBSZ-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA48085

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 275.29

Molecular Weight (Monoisotopic): 275.0252

AlogP: 2.79

#Rotatable Bonds: 1

Polar Surface Area: 93.81

Molecular Species: NEUTRAL

HBA: 6

HBD: 4

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 7.53

CX Basic pKa: 1.62

CX LogP: 2.92

CX LogD: 2.68

Aromatic Rings: 3

Heavy Atoms: 19

QED Weighted: 0.51

Np Likeness Score: -0.09

References

1. Stevens MF, McCall CJ, Lelieveld P, Alexander P, Richter A, Davies DE..  (1994)  Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin.,  37  (11): [PMID:8201603] [10.1021/jm00037a020]

Source

Source(1):

• Scientific Literature